Search Results - "Hedley, Benjamin D"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    The thrombin inhibitor Argatroban reduces breast cancer malignancy and metastasis via osteopontin-dependent and osteopontin-independent mechanisms by Schulze, Erika B., Hedley, Benjamin D., Goodale, David, Postenka, Carl O., Al-Katib, Waleed, Tuck, Alan B., Chambers, Ann F., Allan, Alison L.

    Published in Breast cancer research and treatment (01-11-2008)
    “…Osteopontin (OPN) has been clinically and experimentally associated with breast cancer metastasis. Proteolytic cleavage of OPN by thrombin has been reported to…”
    Get full text
    Journal Article
  5. 5

    The Role of Erythropoietin and Erythropoiesis-Stimulating Agents in Tumor Progression by HEDLEY, Benjamin D, ALLAN, Alison L, XENOCOSTAS, Anargyros

    Published in Clinical cancer research (15-10-2011)
    “…Over the past few decades, understanding of the physiologic function of erythropoietin (EPO) has evolved significantly. EPO binds to erythropoietin receptors…”
    Get full text
    Journal Article
  6. 6

    synthetic triterpenoid CDDO-Imidazolide suppresses experimental liver metastasis by Townson, Jason L, MacDonald, Ian C, Liby, Karen T, Mackenzie, Lisa, Dales, David W, Hedley, Benjamin D, Foster, Paula J, Sporn, Michael B, Chambers, Ann F

    Published in Clinical & experimental metastasis (01-03-2011)
    “…Survival following diagnosis of liver metastasis remains poor and improved treatment strategies to combat liver metastases are needed. Synthetic triterpenoids,…”
    Get full text
    Journal Article
  7. 7

    High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability by Croker, Alysha K., Goodale, David, Chu, Jenny, Postenka, Carl, Hedley, Benjamin D., Hess, David A., Allan, Alison L.

    Published in Journal of cellular and molecular medicine (01-08-2009)
    “…Cancer stem cells (CSCs) have recently been identified in leukaemia and solid tumours; however, the role of CSCs in metastasis remains poorly understood. This…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Novel lymphocyte screening tube using dried monoclonal antibody reagents by Hedley, Benjamin D., Keeney, Michael, Popma, Janice, Chin‐Yee, Ian

    Published in Cytometry. Part B, Clinical cytometry (01-11-2015)
    “…We previously developed a 10‐color 11‐antibody combination including a viability dye, to screen T‐, B‐, and natural killer (NK)‐cell populations in blood, bone…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Measurable Residual Disease Detection in B-Acute Lymphoblastic Leukemia: The Children's Oncology Group (COG) Method by Borowitz, Michael J, Wood, Brent L, Keeney, Michael, Hedley, Benjamin D

    Published in Current protocols (01-03-2022)
    “…Measurable (minimal) residual disease (MRD) in B-acute lymphoblastic leukemia (B-ALL), as assessed by flow cytometry, is an established prognostic factor used…”
    Get more information
    Journal Article
  12. 12
  13. 13

    T‐cell clonality testing for the diagnosis of T‐cell large granular lymphocytic leukemia: Are we identifying pathology or incidental clones? by Chin‐Yee, Benjamin, Suthakaran, Abitha, Hedley, Benjamin D., Howlett, Christopher, Stuart, Alan, Sadikovic, Bekim, Chin‐Yee, Ian H., Hsia, Cyrus C.

    “…Introduction T‐cell clonality testing by T‐cell receptor (TCR) gene rearrangement is key to the diagnosis of T‐cell lymphoproliferative disorders such as…”
    Get full text
    Journal Article
  14. 14

    Tumor dormancy and the role of metastasis suppressor genes in regulating ectopic growth by Hedley, Benjamin D, Allan, Alison L, Chambers, Ann F

    Published in Future oncology (London, England) (01-10-2006)
    “…Metastasis, or tumor growth in an ectopic site, may occur several years after apparently successful treatment of the primary malignancy. Clinical dormancy is…”
    Get more information
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    A multicenter study evaluation of the ClearLLab 10C panels by Hedley, Benjamin D., Cheng, Guoyan, Keeney, Michael, Kern, Wolfgang, Padurean, Adrian, Luider, Joanne, Chin‐Yee, Ian, Lowes, Lori E., Rohrbach, Justin, Ortega, Robert, Smit, Astrid, Lo, Ka‐Wai, Magari, Robert, Tejidor, Liliana

    Published in Cytometry. Part B, Clinical cytometry (01-03-2021)
    “…Multiparameter flow cytometry plays an important role in the diagnosis, staging, and monitoring of patients with a suspected hematological malignancy. The…”
    Get full text
    Journal Article
  20. 20

    User‐defined protein marker assay development for characterization of circulating tumor cells using the CellSearch® system by Lowes, Lori E., Hedley, Benjamin D., Keeney, Mike, Allan, Alison L.

    Published in Cytometry. Part A (01-11-2012)
    “…The majority of cancer‐related deaths result from metastasis, which has been associated with the presence of circulating tumor cells (CTCs). It has been shown…”
    Get full text
    Journal Article